R
Renaud Seigneuric
Researcher at University of Burgundy
Publications - 46
Citations - 2369
Renaud Seigneuric is an academic researcher from University of Burgundy. The author has contributed to research in topics: Cancer & Gene expression. The author has an hindex of 21, co-authored 46 publications receiving 2067 citations. Previous affiliations of Renaud Seigneuric include French Institute of Health and Medical Research & Maastricht University.
Papers
More filters
Journal ArticleDOI
Targeting heat shock proteins in cancer.
Gaëtan Jego,Gaëtan Jego,Adonis Hazoumé,Renaud Seigneuric,Renaud Seigneuric,Renaud Seigneuric,Carmen Garrido +6 more
TL;DR: This review describes the different molecules and approaches being used or proposed in cancer therapy based on the in inhibition of HSP90, HSP70 and HSP27.
Journal ArticleDOI
Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control
Marianne Koritzinsky,Michael G. Magagnin,Twan van den Beucken,Renaud Seigneuric,Kim G.M. Savelkouls,Josée Dostie,Stéphane Pyronnet,Randal J. Kaufman,Sherry A. Weppler,Jan Willem Voncken,Philippe Lambin,Constantinos Koumenis,Nahum Sonenberg,Bradly G. Wouters +13 more
TL;DR: Qualitative RT–PCR analysis of polysomal RNA indicates that the translation efficiency of individual genes varies widely during hypoxia, and regulates mRNA translation through distinct mechanisms each with important contributions to hypoxic gene expression.
Journal ArticleDOI
The small heat shock proteins family : The long forgotten chaperones
TL;DR: In this mini-review, a general introduction about the small heat shock proteins family is presented and their implication in physio-pathological processes and human diseases is now well evidenced.
Journal ArticleDOI
From Nanotechnology to Nanomedicine: Applications to Cancer Research
Renaud Seigneuric,Laurent Markey,D. S. A. Nuyten,C. Dubernet,Chris T. Evelo,Eric Finot,Carmen Garrido +6 more
TL;DR: This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice.
Journal ArticleDOI
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo,Guillaume Marcion,Marine Cordonnier,Alexandre M.M. Dias,Nicolas Pernet,Arlette Hammann,Sarah Richaud,Hajare Mjahed,Nicolas Isambert,Victor Clausse,Cédric Rébé,Aurélie Bertaut,Vincent Goussot,Frédéric Lirussi,François Ghiringhelli,Aurélie de Thonel,Pierre Fumoleau,Renaud Seigneuric,Carmen Garrido +18 more
TL;DR: A8 might be useful for quantifying tumor-derived exosomes and for cancer therapy through MDSC inhibition and the antitumor effect of the drugs was strongly potentiated.